Le Lézard
Classified in: Health
Subjects: MAV, CHI, WOM, CFG

/R E P E A T -- Notice to the media - Minister of Health and Minister for Women and Gender Equality and Rural and Economic Development to announce funding to prevent and address family violence/


OTTAWA, ON, Nov. 24, 2020 /CNW/ - The Honourable Patty Hajdu, Minister of Health, and the Honourable Maryam Monsef, Minister for Women and Gender Equality and Rural and Economic Development, will announce funding to support three initiatives aimed at preventing family violence and supporting survivors.

There will be a media availability immediately following the announcement.

Date
November 25, 2020

Time
9:00 AM (EST)

Location

The event will be held on Zoom.

Zoom link: https://ca01web.zoom.us/j/61520041533
Passcode: 378959

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 22:15
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 21:59
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae Enters into Agreement with Labcorp for Sale of Business
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
/C O R R E C T I O N -- Valcare Medical/
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...

More news about Health...


News published on and distributed by: